BCL-3 enhances β-catenin signalling in colorectal tumour cells promoting a cancer stem cell phenotype
Danny Legge(University of Bristol), Ann C. Williams(Cancer Research UK)
Cited by 0
Related Papers
Cancer cell adaptation to hypoxia involves a HIF‐GPRC5A‐YAP axis
|EMBO Molecular Medicine|2018|93
LGR5 expression is regulated by EGF in early colorectal adenomas and governs EGFR inhibitor sensitivity
|British Journal of Cancer|2017|23
BCL-3 loss sensitises colorectal cancer cells to DNA damage by targeting homologous recombination
|DNA repair|2022|8
Identifying targetable metabolic dependencies across colorectal cancer progression
|Molecular Metabolism|2024|8